Legal & General Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.03M | Sell |
|
|||||
|
2025
Q2 | $3.09M | Buy |
|
|||||
|
2025
Q1 | $3.03M | Sell |
|
|||||
|
2024
Q4 | $2.37M | Buy |
|
|||||
|
2024
Q3 | $1.86M | Sell |
|
|||||
|
2024
Q2 | $3.61M | Sell |
|
|||||
|
2024
Q1 | $3.75M | Buy |
|
|||||
|
2023
Q4 | $4.33M | Sell |
|
|||||
|
2023
Q3 | $3.95M | Sell |
|
|||||
|
2023
Q2 | $5.29M | Sell |
|
|||||
|
2023
Q1 | $5.41M | Sell |
|
|||||
|
2022
Q4 | $5.13M | Buy |
|
|||||
|
2022
Q3 | $7M | Sell |
|
|||||
|
2022
Q2 | $7.69M | Buy |
|
|||||
|
2022
Q1 | $9.96M | Buy |
|
|||||
|
2021
Q4 | $7.65M | Buy |
|
|||||
|
2021
Q3 | $6.89M | Buy |
|
|||||
|
2021
Q2 | $6.88M | Sell |
|
|||||
|
2021
Q1 | $9.97M | Buy |
|
|||||
|
2020
Q4 | $8.24M | Buy |
|
|||||
|
2020
Q3 | $8.2M | Buy |
|
|||||
|
2020
Q2 | $7.05M | Buy |
|
|||||
|
2020
Q1 | $4.16M | Buy |
|
|||||
|
2019
Q4 | $5.6M | Buy |
|
|||||
|
2019
Q3 | $3.85M | Buy |
|
|||||
|
2019
Q2 | $751K | Buy |
|
|||||
|
2019
Q1 | $642K | Buy |
|
|||||
|
2018
Q4 | $717K | Buy |
|
|||||
|
2018
Q3 | $763K | Buy |
|
|||||
|
2018
Q2 | $496K | Sell |
|
|||||
|
2018
Q1 | $516K | Sell |
|
|||||
|
2017
Q4 | $877K | Sell |
|
|||||
|
2017
Q3 | $742K | Buy |
|
|||||
|
2017
Q2 | $620K | Buy |
|
|||||
|
2017
Q1 | $563K | Sell |
|
|||||
|
2016
Q4 | $401K | Buy |
|
|||||
|
2016
Q3 | $293K | Sell |
|
|||||
|
2016
Q2 | $322K | Buy |
|
|||||
|
2016
Q1 | $403K | Buy |
|
|||||
|
2015
Q4 | $539K | Hold |
|
|||||
|
2015
Q3 | $289K | Buy |
|
|||||
|
2015
Q2 | $459K | Buy |
|
|||||
|
2015
Q1 | $568K | Buy |
|
|||||
|
2014
Q4 | $474K | Sell |
|
|||||
|
2014
Q3 | $521K | Buy |
|